Cargando…
Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor
The COVID-19 pandemic caused by the severe acute syndrome virus 2 (SARS-CoV-2) has been around since November 2019. As of early June 2022, more than 527 million cases were diagnosed, with more than 6.0 million deaths due to this disease. Coronaviruses accumulate mutations and generate greater divers...
Autores principales: | Andrade, Sonia Aparecida, Batalha-Carvalho, João Victor, Curi, Rui, Wen, Fan Hui, Covas, Dimas Tadeu, Chudzinski-Tavassi, Ana Marisa, Moro, Ana Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310548/ https://www.ncbi.nlm.nih.gov/pubmed/35898497 http://dx.doi.org/10.3389/fimmu.2022.871874 |
Ejemplares similares
-
Prediction of antibody binding to SARS-CoV-2 RBDs
por: Wang, Eric
Publicado: (2023) -
Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses
por: Xu, Zepeng, et al.
Publicado: (2022) -
Structural Basis of Rnd1 Binding to Plexin Rho GTPase Binding Domains (RBDs)
por: Wang, Hui, et al.
Publicado: (2011) -
Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
por: Zhang, Zhi-Bi, et al.
Publicado: (2022) -
Impact of mutations on the plant-based production of recombinant SARS-CoV-2 RBDs
por: Ruocco, Valentina, et al.
Publicado: (2023)